Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach

被引:23
|
作者
Fidalgo, P
Almeida, MR
West, S
Gaspar, C
Maia, L
Wijnen, J
Albuquerque, C
Curtis, A
Cravo, M
Fodde, R
Leitao, CN
Burn, J
机构
[1] Univ Newcastle Upon Tyne, No Genet Serv, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England
[3] Inst Porugues Oncol, Dept Gastroenterol, Lisbon, Portugal
[4] Leiden State Univ, Inst Human Genet, Leiden, Netherlands
关键词
mutation detection; hereditary non-polyposis colorectal cancer; single strand conformation polymorphism; heteroduplex analysis; denaturing gradient gel electrophoresis; protein truncation test;
D O I
10.1038/sj.ejhg.5200393
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutation searching was performed in the hMSH2 and hMLH1 genes in 20 Portuguese families representing 124 registered affected individuals. Of the 20, 16 fulfilled the classic 'Amsterdam' criteria for HNPCC, whereas the remaining four families satisfied a modified set of criteria. These criteria required a CRC diagnosed before age 50years and cancers diagnosed in two other relatives within the HNPCC spectrum. A multi-method approach was performed using the protein truncation test (PTT), single strand conformation polymorphism (SSCP) with two different sets of conditions, heteroduplex analysis (HA) and denaturing gradient gel electrophoresis (DGGE). Putative phenotype-genotype correlations were also explored. Ten different germline mutations were identified. Six of these were found in hMLH1 in seven families and four in hMSH2 in four families. SSCP and DGGE had the highest diagnostic yields with the percentage of variants detected above 67% and together HA and PTT had the lowest. No single technique detected all variants. Trends for the absence of extracolonic manifestations were observed in families carrying hMLH1 germline mutations (four of seven in hMLH1 vs one of four in hMSH2). Most of the families with rectal cancer were associated with hMLH1 (six of seven in hMLH1 vs two of four in hMSH2). A multi-technique approach is necessary to identify a high percentage of germline mutations. Seven novel mutations were found in this Portuguese population.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [21] Distinct mutations in MLH1 and MSH2 genes in Hereditary Non-polyposis Colorectal Cancer (HNPCC) families from China
    Wei, Wenqian
    Liu, Fangqi
    Liu, Lei
    Li, Zuofeng
    Zhang, Xiaoyan
    Jiang, Fan
    Shi, Qu
    Zhou, Xiaoyan
    Sheng, Weiqi
    Cai, Sanjun
    Li, Xuan
    Xu, Ye
    Nan, Peng
    BMB REPORTS, 2011, 44 (05) : 317 - 322
  • [22] The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC)
    Vasen, HFA
    Sanders, EACM
    Taal, BG
    Nagengast, FM
    Griffioen, G
    Menko, FH
    Kleibeuker, JH
    HouwingDuistermaat, JJ
    Khan, PM
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (04) : 422 - 425
  • [23] Collection of Italian Hereditary Non-Polyposis Colorectal Cancer (HNPCC) pedigrees
    Arrigoni, A
    Bargiacchi, S
    Benatti, P
    Heouaine, A
    Mareni, C
    Messerini, L
    Montera, MP
    Mori, S
    Percesepe, A
    Presciuttini, S
    Rocci, MP
    Sala, P
    TUMORI, 1996, 82 (02) : 151 - 179
  • [24] Clinical aspects and management of hereditary non-polyposis colorectal cancer (HNPCC)
    Bertario, L
    Aste, H
    Arrigoni, A
    Fracasso, P
    Rossini, FR
    Rossetti, C
    Valanzano, R
    TUMORI, 1996, 82 (02) : 117 - 121
  • [25] Hereditary non-polyposis colorectal cancer (HNPCC). Syndromes and genetic factors
    Puisieux, A
    EUROCANCER 96 - PROCEEDINGS OF THE NINTH CONGRESS, 1996, : 155 - 156
  • [26] Evaluation of genetic testing for hereditary non-polyposis colorectal cancer (HNPCC)
    Walpole, IR
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (07) : 308 - 309
  • [27] Characterization of two novel mutations in mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Chong, GL
    Yuan, ZQ
    MacNamara, E
    Gordon, PH
    Foulkes, WD
    CLINICAL CHEMISTRY, 2000, 46 (06) : A202 - A202
  • [28] Bleomycin sensitivity in patients with hereditary non-polyposis colorectal cancer (HNPCC)
    Kladny, J
    Zajaczek, S
    Lubinski, J
    CYTOGENETICS AND CELL GENETICS, 1997, 77 (1-2): : P367 - P367
  • [29] DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer
    NystromLahti, M
    Wu, Y
    Moisio, AL
    Hofstra, RMW
    Osinga, J
    MEcklin, JP
    Jarvinen, HJ
    Leisti, J
    Buys, CHCM
    delaChapelle, A
    Peltomaki, P
    HUMAN MOLECULAR GENETICS, 1996, 5 (06) : 763 - 769
  • [30] Frequency of malignant neoplasms in Brazilian families with hereditary non-polyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC)
    Ferreira, CN
    Ferreira, FO
    Rossi, BM
    Nakagawa, W
    Santos, EM
    Lopes, A
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (01) : S65 - S65